Cardiac Drug Therapy Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Cardiac Drug Therapy book. This book definitely worth reading, it is an incredibly well-written.
Author : M. Gabriel Khan Publisher : Springer Science & Business Media Page : 420 pages File Size : 54,8 Mb Release : 2007-10-14 Category : Medical ISBN : 9781597452380
This book addresses the pharmacology and therapeutic application of drugs used to treat heart diseases and hypertension. Additions and updates to the sixth edition include six new chapters on current controversies in cardiac drug therapy such as the beta blocker issue many cardiologists are presently grappling with. The book provides practical advice on how to manage cardiac diseases and addresses the choice of one particular cardiac agent vs. another.
This sixth edition of a 5x8" reference contains a new chapter on recent clinical trials, expanded material on beta blockers, new cardiac arrest treatment algorithms, expanded drug administration and dosage tables, and critical appraisals of current hypertension management guidelines from various organizations. Khan teaches medicine at the University of Ottowa. Annotation (c)2003 Book News, Inc., Portland, OR (booknews.com).
This book addresses the pharmacology and therapeutic application of drugs used to treat heart diseases and hypertension. Additions and updates to the sixth edition include six new chapters on current controversies in cardiac drug therapy such as the beta blocker issue many cardiologists are presently grappling with. The book provides practical advice on how to manage cardiac diseases and addresses the choice of one particular cardiac agent vs. another.
Cardiovascular Drug Therapy in the Elderly by Adam Schneeweiss,Gotthard Schettler Pdf
Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed.
Current Cardiovascular Drugs by William H. Frishman,Angela Cheng-Lai,Julie Chen Pdf
The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.
Author : M. Gabriel Khan,M. I. Gabriel Khan Publisher : London : B. Tindall Page : 328 pages File Size : 48,8 Mb Release : 1988 Category : Medical ISBN : 0702012661
Antithrombotic Drug Therapy in Cardiovascular Disease by Arman T. Askari,A. Michael Lincoff Pdf
Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticoagulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).
A pocket-sized guide to the complexities of modern cardiovascular drug therapy. This revised edition provides up-to-date coverage of all aapects of late-1990s cardiac drug usage.
Cardiovascular Pharmacotherapeutics by William H. Frishman, MD,Domenic A. Sica, MD Pdf
Everything practicing physicians and pharmacists need to know about drug therapy for cardiovascular disease. A critically acclaimed classic reference now in its third edition, Cardiovascular Pharmacotherapeutics provides current information regarding the contemporary use of all available cardiovascular medications for adults and children. Strongly emphasizing the scientific rationale behind the use of such therapies in cardiac disease, it discusses new drugs and novel compounds that are under development and may emerge as the cardiac therapies of the future. This edition also addresses special considerations for drug therapy use in the elderly, during pregnancy, and in those with hepatic or renal disease. A generous assortment of tables, figures, and appendices guides readers in their investigations of each drug group and various disease states. This new third edition presents an in-depth discussion of: All cardiovascular agents currently available The scientific basis behind every pharmacotherapy advance Mechanisms of action of cardiovascular pharmacotherapeutics The latest advances in cardiovascular drug therapy Specific drug treatments, and information on recently approved drugs Molecular biological advances Drugs in development Hands-on discussions of how to utilize specific drugs for treatment of various cardiovascular disorders and for the prevention of disease Also included are 8 appendices that provide practical, hands-on information on using drugs in clinical settings, including relevant pharmacokinetic information, and practical drug prescribing information. All updated with an accompanying website, Advances in Cardiovascular Pharmacotherapeutics www.cvpct3.com
Cardiac Drugs in Pregnancy by Karen Sliwa,John Anthony Pdf
The spectrum of cardiovascular disease affecting women in pregnancy and postpartum is changing and differs between countries. In the western world, the risk of cardiovascular disease in pregnancy has increased due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading also to early diabetes and hypertension. In addition the treatment of congenital heart disease has improved leading to an increased number of women with residual heart disease reaching childbearing age. In the western world maternal heart disease is now the major cause of maternal death during pregnancy. In the developing world rheumatic heart disease and the cardiomyopathies dominate. Those women often need anticoagulation as they might have had a valve replacement or formed a thrombus in the left heart. Drugs during pregnancy and the breastfeeding period is a complex subject and there is a profound shortage of evidence based recommendations. As drug treatment in pregnancy concern the mother and the fetus optimum treatment of both must be targeted. This book aims at discussing the most important indications of drug usage in pregnancy and postpartum with the aim of weighing the potential risk of a drug and the possible benefit against each other.
Dennis A. Tighe,Maichi T. Tran,Jennifer L. Donovan,James R. Cook
Author : Dennis A. Tighe,Maichi T. Tran,Jennifer L. Donovan,James R. Cook Publisher : Jones & Bartlett Publishers Page : 569 pages File Size : 42,6 Mb Release : 2010-03-10 Category : Medical ISBN : 9781449671495
Cardiology Drug Guide 2010 by Dennis A. Tighe,Maichi T. Tran,Jennifer L. Donovan,James R. Cook Pdf
A One-Stop Reference for Cardiovascular Drugs Cardiology Drug Guide 2010 is the authoritative reference book on cardiovascular medications for cardiologists, primary care physicians, physicians in training, physician assistants and any health care professional managing drug therapy regimens in patients with cardiovascular disease. This essential resource is updated annually and offers comprehensive data on the science and application of cardiovascular drugs available today, including pharmacology, administration and dosages. This unique guide also includes a chapter on prescribing drugs for common cardiovascular conditions. Key features include: • Comprehensive drug information including trade and generic names; important interactions, contraindications and precautions • Summary tables in every chapter for quick reference • Practical frameworks for prescribing cardiovascular drugs • Free CD-Rom with a fully-searchable version of the book in its entirety
Handbook of Pediatric Cardiovascular Drugs by Ricardo Munoz,Eduardo M. da Cruz,Carol G. Vetterly,David S. Cooper,Donald Berry Pdf
A Second Edition of this handbook of drugs used in pediatric cardiac care will satisfy the need for a quick up-to-date reference source of common drug therapy. There are no major texts available in the field of pediatric cardiology that exclusively provide therapeutic drug information. Several sources are available that present drug information for cardiology, but these place no emphasis on pediatric care and are written for general cardiac specialists.
